Summary
Folates are a group of compounds which are required in the diet and are important in DNA, amino acids and possibly also amine metabolism. The biologically active folates are in the tetrahydro form. Tetrahydrofolates are produced from unreduced dietary folates by the enzyme dihydrofolate reductase. A number of drugs such as aminopterin, methotrexate (amethopterin), pyrimethamine, trimethoprim and triamterene act as folate antagonists and produce folate deficiency by inhibiting this enzyme. With other drugs which produce low serum and tissue concentrations of folate such as anticonvulsants, antituberculosis drugs, alcohol and oral contraceptives, the mechanism of this effect is uncertain. Possible mechanisms include reduced absorption, prevention of release of folate from tissue stores, altered plasma protein binding, or increased folate metabolism in the liver.
Treatment with folic acid antagonists such as methotrexate readily causes megaloblastic anaemia; this can be prevented by therapy with folinic acid (5-formyltetrahydrofolate). The role of other drugs in producing megaloblastic anaemia is less certain, e.g. it occurs in less than 0.75% of patients receiving anticonvulsants. The possible neurological and psychiatric effects of folate deficiency are also uncertain. However, in patients with folate deficiency who have neuropsychiatric symptoms, neuropathy or myelopathy, and normal vitamin B12 levels, it may be of value to try therapy with folic or folinic acid.
Similar content being viewed by others
References
Ahmed, M.: Neurological disease and folate deficiency. British Medical Journal 1: 181 (1972).
Allen, R.J.; DiMauro, S.; Coulter, D.L.; Papadimitriou, A. and Rothenberg, S.P.: Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Annals of Neurology 13: 679–682 (1983).
Alperin, J.B. and Haggard, M.E.: Cerebrospinal fluid folate and the blood brain barrier. Clinical Research 18: 40 (1970).
Anand, M.P.: Iatrogenic megaloblastic anaemia with neurological complications. Scottish Medical Journal 9: 388–390 (1964).
Arakawa, T.; Ohara, K. and Kudo, Z.: Hyperfolic-acidemia with formiminoglutamic-aciduria following histidinc loading. Suggested for a case of congenital deficiency in formiminotransferasc. Tohoku Journal of Experimental Medicine 80: 370–382 (1963).
Ariel, M.; Eilam, Y.; Jablonska, M. and Grossowicz, N.: Effect of Phenytoin on folic acid uptake in isolated intestinal epithelial cells. Journal of Pharmacology and Experimental Therapeutics 233: 224–226 (1982).
Bachevalier,.J. and Botez, M.I.: Behavioral effects of folic acid deficiency and folate oversupplementation in postweanling rats: in Botez and Reynolds (Eds) Folic Acid in Neurology, Psychiatry, and Internal Medicine (Raven Press, New York 1979).
Bachevalier, J.; Botez, M.I. and Maag, V.: Learning deficits in folate-deficient rats reversible with folic acid or thiamine replacement therapv. Nutrition Reports International 23: 617–627(1981).
Baugh, CM. and Krumdieck, C.L.: Effects of Phenytoin on folicacid conjugases in man. Lancet 2: 519–521 (1969).
Baylis, E.M.; Crowley, J.M.. Preecc, J.M.; Sylvester, P.E. and Marks, V.: Influence of folic acid on blood-phenytoin levels. Lancet 1: 62–64 (1971).
Blakley, R.L.: The Biochemistry of Folic Acid and Related Pteridines (North Holland Publishing Company, Amsterdam 1969).
Bonnycastle, D.D.; Giarman, N.J. and Paasonen, M.K.: Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. British Journal of Pharmacology 12: 228–231 (1957).
Botez, M.I.; Botez, T.; Léveillé, J.; Bielmann, P. and Cadotte, M.: Neuropsychological correlates of folic acid deficiency: Facts and hypotheses: in Botez and Reynolds (Eds) Folic Acid in Neurology. Psychiatry, and Internal Medicine, pp. 435–461 (Raven Press, New York 1979a).
Botez, M.I.; Cadotte, M.. Beaulieu, R.; Pickettc, L.P. and Pison, C.: Neurologic disorders responsive to folic acid therapy. Canadian Medical Association Journal 115: 217–223 (1976).
Botez, M.I.; Peyronnard, J.M.; Bachevalier, J. and Charron, L.: Polyneuropathy and folate deficiency. Archives of Neurology 35: 581–584 (1978).
Botez, M.I.; Young, S.N.; Bachevalier, J. and Gauthier, S.: Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature 278: 182–183 (1979b).
Botcz, M.I.; Young, S.N.; Bachevalier, J. and Gauthier, S.: Effect of folic acid and vitamin B12: deficiencies on 5-hydroxyindole acetic acid in human cerebrospinal fluid. Annals of Neurology 12: 479–484 (1982).
Canloni, G.L.: Biological methylation: Selected aspects. Annual Review of Biochemistry 44: 435–451 (1975).
Carney, M.W.P. and Sheffield, B.F.: Associations of subnormal scrum folate and vitamin B12 values and effects of replacement therapy. Journal of Nervous and Mental Disease 150: 404–412 (1970).
Chadwick, D.; Jenner, P. and Reynolds, E.H.: Amines, anticonvulsants and epilepsy. Lancet 1: 473–476 (1975).
Chan, M.K.; Beale, D. and Moorhead, J.F.: Acute megaloblastosis due to Cotrimoxazole. British Journal of Clinical Practice 34: 187–188 (1980).
Chanarin, I.: Effects of anticonvulsant drugs: in Botez and Reynolds (Eds) Folic Acid in Neurology, Psychiatry, and Internal Medicine, pp. 75–80 (Raven Press, New York 1979).
Chase, T.N.; Katz, R.I. and Kopin, I.J.: Effect of anticonvulsants on brain serotonin. Transactions of the American Neurological Association 94: 236–238 (1969).
Cooper, B.A. and Lowenstein, L.: Relative folate deficiency of erythrocytes in pernicious anaemia and its correction with cyanocobalamin. Blood 24: 502–521 (1964).
Coppen, A. and Abou-Saleh, M.T.: Plasma folate and affective morbidity during long-term lithium therapy. British Journal of Psychiatry 141: 87–89 (1982).
Corcino, J.; Waxman, S. and Herbert, V.: Mechanism of triamterene-induced megaloblastosis. Annals of Internal Medicine 73: 419–424 (1970).
Dennis, J. and Taylor, D.C.: Epilepsy and folate deficiency. British Medical Journal 4: 807–808 (1969).
Druskin, M.S.; Wallen, M.H. and Bonagura, L.: Anticonvulsant-associated megaloblastic anaemia. New England Journal of Medicine 267: 483–485 (1962).
Eichner, E.R. and Hillman, R.S.: Effect of alcohol on serum folate level. Journal of Clinical Investigation 52: 584–591 (1973).
FAO/WHO Expert Group: Requirements of ascorbic acid, vitamin D. vitamin B12 folate and iron. World Health Organization Technical Report (WHO, Geneva 1970).
Fehling, C. Jägerstad, M.; Lindstrand, K. and Elmqvist, D.: Folate deficiency and neurological disease. Archives of Neurology 30: 263–265 (1974).
Freeman, J.M.; Finkelstcin, J.D. and Mudd, S.H.: Folate-responsive homocystinuria ‘schizophrenia’. A defect in methylation due to deficient 5.10-mcthylenetetrahydrofolate reductase activity. New England Journal of Medicine 292: 491–496 (1975).
Furlanut, M.; Benetello, P.; Avogaro, A. and Dainese, R.: Effects of folic acid on Phenytoin kinetics in healthy subjects. Clinical Pharmacology and Therapeutics 24: 294–297 (1978).
Garelis, E. and Sourkes, T.L.: Factors affecting monoamine metabolite concentrations in the cerebrospinal fluid. Neurology 22: 1151–1159 (1973).
Gerson, CD.; Hepner, G.W.; Brown, N.; Cohen, N.; Herbert, V. and Janowitz, H.D.: Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology 63: 246–251 (1972).
Gibberd, F.B.; Nicholls, A. and Wright, M.G.: The influence of folic acid on the frequency of epileptic attacks. European Journal of Clinical Pharmacology 19: 57–60 (1981).
Gird wood, R.H.: Trimethoprim/sulphamethoxazole: Long-term therapy and folate levels. Medical Journal of Australia (Special Supplement): 34–36 (June 1973).
Grace, E.; Emans, J. and Drum, D.E.: Hematologic abnormalities in adolescents who take oral contraceptive pills. Journal of Pediatrics 101: 771–774 (1982).
Grant, H.C.; Hoffbrand, A.V. and Wells, D.G.: Folate deficiency and neurological disease. Lancet 2: 763–767 (1965).
Grant, R.H.E. and Stores, O.P.R.: Folic acid in folate-deficient patients with epilepsy. British Medical Journal 4: 644–648 (1970).
Halsted, CH.: Intestinal absorption and malabsorption of folates. Annual Review of Medicine 31: 79–87 (1980).
Halsted, CH.; Gandhi, G. and Tamura, T.: Sulfasalazine inhibits the absorption of folates in ulcerative colitis. New England Journal of Medicine 305: 1513–1517 (1981).
Hansen, H.A.. Nordqvist, P. and Sourander, P.: Megaloblastic anemia and neurologic disturbances combined with folic acid deficiency: Observations on an epileptic patient treated with anticonvulsants. Acta Medica Scandinavica 176: 243–251 (1964).
Hepner, G.W.; Booth, CC; Cowan, J.; Hoffbrand, A.V. and Mollin, D.L.: Absorption of crystalline folic acid in man. Lancet 2: 302–306 (1968).
Herbert, V.: Minimal daily adult folate requirement. Archives of Internal Medicine 110: 649–652 (1962a).
Herbert, V.: Experimental nutritional folate deficiency in man. Transactions of the Association of American Physicians 125: 307–320 (1962b).
Hibbard, E.D. and Smithels, R.W.: Folic acid metabolism and human embryopathy. Lancet 1: 1254 (1965).
Hiilesmaa, V.K.; Teramo, K.; Granström, ML. and Bardy, A.H.: Serum folate concentrations during pregnancy in women with epilepsy: Relation to antiepileptic drug concentrations, number of seizures, and fetal outcome. British Medical Journal 287: 577–579 (1983).
Hillman, R.S. and Steinberg, S.E.: The effects of alcohol on folate metabolism. Annual Review of Medicine 33: 345–354 (1982).
Hoffbrand, AV.: Pernicious anaemia. Scottish Medical Journal 28: 218–227 (1983).
Hoffbrand, A.V. and Necheles, T.F.: Mechanism of folate deficiency in patients receiving Phenytoin. Lancet 2: 528–530 (1968).
Hoffbrand, A.V.; Newcombe, B.F.A. and Mollin, D.L.: Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. Journal of Clinical Pathology 19: 17–28 (1966).
Horwitz, S.J.; Klipstein, F.A. and Lovelace, R.E.: Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. Lancet 1: 563–565 (1968).
Hunter, R.; Barnes, J.; Curzon, G.; Kantamaneni, B.D. and Duncan, C: Effect of folic acid by mouth on cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentration. Journal of Neurology. Neurosurgery and Psychiatry 34: 571–575 (1971).
Hurdle, A.D.F. and Picton-Williams, T.C: Folic acid deficiency in elderly patients admitted to hospital. British Medical Journal 2: 202–205 (1966).
Jensen, O.N. and Olesen, O.V.: Subnormal scrum folate due to anticonvulsive therapy: A double-blind study of the effect of folic acid treatment in patients with drug-induced subnormal serum folates. Archives of Neurology 22: 181–182 (1970).
Klipstein, F.A.; Berlinger, F.G. and Reed, L.J.: Folate deficiency associated with drug therapy for tuberculosis. Blood 29: 697–712 (1967).
Kohn, J.; Mollin, D.L. and Rosenbach, L.M.: Conventional voltage electrophoresis for formiminoglutamic-acid determination in folic acid deficiency. Journal of Clinical Pathology 14: 345–350 (1961).
Kutt, H.; Winter, W. and McDowell, F.H.: Depression of parahydroxylalion of diphenylhydantoin by antituberculosis therapy. Neurology 16: 594–602 (1966).
Labadarios, D.; Dickerson, J.W.T.; Parke, D.V.; Lucas, E.G. and Obuwa, G.H.: The effects of chronic drug administration on hepatic enzyme induction and folate metabolism. British Journal of Clinical Pharmacology 5: 167–173 (1978).
Laduron, P.: N-methylation of dopamine to epinephrine in brain tissue using N-methyltetrahydrofolic acid as methyl donor. Nature (New Biology) 238: 212–213 (1972).
Lambie, D.G.: Anticonvulsant drugs: Their therapeutic and biochemical effects in epileptic patients (Ph.D Thesis, University of Glasgow. 1977).
Lane, F.; Goff, P.; McGuffin, R.; Eichner, E.R. and Hillman, R.S.: Folic acid metabolism in normal, folate deficient and alcoholic man. British Journal of Haematology 34: 489–500 (1976).
Lan/kowsky, P.; Erlandson, M.E. and Bezan, A.I.: Isolated defect of folic acid absorption associated with mental retardation and cerebral calcification. Blood 34: 452–456 (1969).
Laurence, K.M.; James, N.; Miller, M.H.; Tennant, G.B. and Campbell, H.: Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. British Medical Journal 282: 1509–1511 (1981).
Levitt, M.; Nixon, P.F.; Pincus, J.H. and Bertino, J.R.: Transport characteristics of folates in cerebrospinal fluid: A study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahvdrofolate. Journal of Clinical Investigation 50: 1301–1308 (1971).
Lindenbaum, J. and Lieber, CS.: Hematologic effects of alcohol in man in the absence of nutritional deficiency. New England Journal of Medicine 281: 333–338 (1969).
Long, M.T.; Childress, R.H. and Bond, W.H.: Megaloblastic anemia associated with the use of anticonvulsant drugs: Report of a case and review of the literature. Neurology 13: 697–702 (1963).
Longstreth, G.F. and Green, R.: Folate status in patients receiving maintenance doses of sulfasalazine. Archives of Internal Medicine 143: 902–904 (1983).
McGuffin, R.. Goff, P. and Hillman, R.S.: The effect of diet and alcohol on the development of folate deficiency in the rat. Journal of Haematology 31: 185–192 (1975).
Mannheimer, E.; Pakesch, F.; Reimer, E.E. and Vetter, H.: Die hematologischen komplikationen der epilepsiebehandlung mit Hydantoinkorpem. Medizinische Klinik 47: 1397 (1952).
Manzoor, M. and Runcie, J.: Folate-responsive neuropathy: Report of 10 cases. British Medical Journal 1: 1176–1178 (1976).
Markkanen, T.. Himanen, P.; Pajula, R.L. and Molnar, G.: Binding of folic acid to serum proteins: II. The effect of diphenylhvdanloin and of various diseases. Acta Haematologica 50: 284–292 (1973a).
Markkanen, T.; Pajula, R.L.; Himanen, P. and Virtanen, S.: Serum folate activity (L. casei) in Sephadex gel chromatography. Journal of Clinical Pathology 26: 486–493 (1973b).
Martinez, O. and Roe, D.A.: Effect of oral contraceptives on blood folate levels in pregnancy. American Journal of Obstetrics and Gynecology 128: 255–261 (1977).
Martinez Figueroa, A.; Johnson, R.H.; Lambie, D.G. and Shakir, R.A.: The role of folate deficiency in the development of peripheral neuropathy caused by anticonvulsants. Journal of the Neurological Sciences 48: 3l5–323 (1980).
Mattson, R.H.; Gallagher, B.B.; Reynolds, E.H. and Glass, D.: Folate therapy in epilepsy. Archives of Neurology 29: 78–81 (1973).
Maxwell,.J.D.; Hunter, J.; Steward, D.A.; Ardeman, S. and Williams, R.: Folate deficiency after anticonvulsant drugs: An effect of hepatic enzyme induction? British Medical Journal 1: 297–299 (1972).
Meller, E.. Rosengarten, H.; Friedhoff, A.J.; Stebbins, R.D. and Silber, R.: 5-Methyltetrahydrofolic acid is not a methyl donor for biogenic amines: Enzymatic formation of formaldehyde. Science 187: 171–173 (1975).
Moir, A.T.B.; Halliday, J. and Williams, I.R.: Lack of effect of folic-acid administration on cerebral metabolism. Lancet 2: 798–800 (1971).
Necheles, T.F. and Snyder, L.M.: Malabsorption of folate polyglutamates associated with oral contraceptive therapy. New England Journal of Medicine 282: 858–859 (1970).
Neubauer, C: Mental deterioration in epilepsy due to folate deficiency. British Medical Journal 2: 759–761 (1970).
Noker, P.E. and Tephly, T.R.: The role of folates in methanol toxicity. Advances in Experimental Medicine and Biology 132: 305–315 (1980).
Norris, J.W. and Pratt, R.F.: A controlled study of folic acid in epilepsy. Neurology 21: 659–664 (1971).
Papeschi, R.. Molina-Negro, P.; Sourkes, T.L. and Erba, G.: The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF: Studies in patients with extrapyramidal disorders, epilepsy, and other diseases. Neurology 22: 1151–1159 (1972).
Paton, A.: Oral contraceptives and folate deficiency. Lancet 1: 418 (1969).
Perry, J. and Chanarin, I.: Intestinal absorption of reduced folate compounds in man. British Journal of Haematology 18: 329–339 (1970).
Pincus, J.; Reynolds, E.H. and Glaser, G..: Subacute combined system degeneration with folate deficiency. Journal of the American Medical Association 221: 496–497 (1972).
Preece,.J.; Reynolds, E.H. and Johnson, A.L.: Relation of serum to red cell folate concentrations in drug-treated epileptic patients. Epilepsia 12: 335–350 (1971).
Ralston, A.J.; Snaith, R.P. and Hinley, R.P.: Effects of folic acid on fit-frequency and behaviour in epileptics on anticonvulsants. Lancet 1: 867–868 (1970).
Reynolds, E.H.: Effects of folic acid on the mental state and fitfrequency of drug-treated epileptic patients. Lancet 1: 1086–1088 (1967a).
Reynolds, E.H.: Schizophrenia-like psychoses of epilepsy and disturbances of folate and vitamin B12 metabolism induced by anticonvulsant drugs. British Journal of Psychiatry 113: 911–919 (1967b).
Reynolds, E.H. Diphenylhydantoin: Hematologic aspects of toxicity: in Woodbury et al. (Eds) Antiepileptic Drugs, pp. 247–262 (Raven Press, New York 1972).
Reynolds, E.H.: Anticonvulsants, folic acid, and epilepsy. Lancet l: 1376–1378 (1973).
Reynolds, E.H.; Chadwick, D.; Jenner, P. and Chanarin, I.: Folate and monoamine metabolism in epilepsy. Journal of the Neurological Sciences 26: 605–615 (1975).
Reynolds, E.H.; Chanarin, L; Milner, G. and Mathews, D.M.: Anticonvulsant therapy, folic acid and vitamin B12: metabolism and mental symptoms. Epilepsia 7: 261–270 (1966).
Reynolds, E.H.; Preece, J. and Chanarin, L.: Folic acid and anticonvulsants. Lancet 1: 1264–1265 (1969).
Robertson, D.M.; Dinsdale, H.B. and Campbell, R.J.: Subacute combined degeneration of the spinal cord — no association with vitamin B12 deficiency. Archives of Neurology 24: 203–209 (1971).
Rose, M. and Johnson, L: Reinterpretation of the haematological effects of anticonvulsant treatment. Lancet 1: 1349–1350 (1978).
Scott,.J.M. and Weir, D.G.: The methyl folate trap. Lancet 2: 337–340 (1981).
del Ser Quijano, T.; Pareja, F.B.; Munoz-Garcia, D. and Sánchez, A.P.: Psychological disturbances and folic acid in chronic epileptic outpatients. Epilepsia 24: 588–596 (1983).
Shojania, A.M.: Oral contraceptives: Effects on folate and vitamin B12 metabolism. Canadian Medical Association Journal 126: 244–247 (1982).
Shojania, A.M.; Hornady, G. and Barnes, P.H.: Oral contraceptives and serum-folatc level. Lancet 1: 1376–1377 (1968).
Shojania, A.M.; Hornady, G.J. and Barnes, P.H.: The effect of oral contraceptives on folate metabolism. American Journal of Obstetrics and Gynecology 111: 782–791 (1971).
Shojania, A.M.; Hornady, G.J. and Scaletta, D.: The effect of oral contraceptives on folate metabolism. III. Plasma clearance and urinary folate excretion. Journal of Laboratory and Clinical Medicine 85: 185–190 (1975).
Shorvon, S.D.: Anticonvulsant therapy and peripheral neuropathy: in Botez and Reynolds (Eds) Folic Acid in Neurology, Psychiatry, and Internal Medicine, pp. 335–347 (Raven Press, New York 1979).
Shulman, E.R.: An overview of folic acid deficiency and psychiatric illness: in Botez and Reynolds (Eds) Folic Acid in Neurology. Psychiatry, and Internal Medicine, pp. 433–474 (Raven Press, New York 1979).
Smithels, R.W.; Sheppard, S. and Schorah, C.J.: Nutritional deficiencies and neural tube defects. Archives of Disease in Childhood 51: 944–950 (1976).
Spray, G.H.: Oral contraceptives and serum-folate levels. Lancet 2: 110–111 (1968).
Spray, G.H. and Burns, D.G.: Folate deficiency and anticonvulsant drugs. British Medical Journal 2: 167 (1972).
Stephens, M.E.M.; Craft, L; Peters, T.J. and Hoffbrand, A.V.: Oral contraceptives and folate metabolism. Clinical Science 42: 405–414 (1972).
Strachan, R.W. and Henderson, J.G.: Dementia and folate deficiency. Quarterly Journal of Medicine 36: 189–204 (1967).
Streiff, R.R.: Malabsorption of polyglutamic acid secondary to oral contraceptives. Clinical Research 17: 345 (1969).
Streiff, R.R.: Folate deficiency and oral contraceptives. Journal of the American Medical Association 214: 105–108 (1970).
Streiff, R.R. and Greene, B.: Drug inhibition of folate conjugase. Clinical Research 18: 418 (1970).
Su, P.C.: Congenital folate deficiency. New England Journal of Medicine 294: 1128 (1976).
Swinson, CM.; Perry, J.; Lumb, M. and Levi, A.J.: Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis. Gut 22: 456–461 (1981).
Tamura, T. and Halsted, CH.: Folate turnover in chronically alcoholic monkeys. Journal of Laboratory and Clinical Medicine 101: 623–628 (1983).
Tauro, G.P.; Danks, D.M.; Rowe, P.B.; Van der Weyden, M.B.; Schwart, M.A.; Collins, V.L. and Neal, B.W.: Dihydrofolate reductase deficiency causing megaloblastic anemia in two families. New England Journal of Medicine 294: 466–470 (1976).
Thiersch, J.B.: Therapeutic abortions with a folic antagonist, 4-aminoptcroylglutamic acid (4-amino PGA) administered by the oral route. American Journal of Obstetrics and Gynecology 63: 1298–1304 (1952).
Trimble, M.R.; Corbett, J.A. and Donaldson, D.: Folic acid and mental symptoms in children with epilepsy. Journal of Neurology. Neurosurgery and Psychiatry 43: 1030–1034 (1980).
Turner, A.J.: The roles of folate and pteridine derivatives in neurotransmitter metabolism. Biochemical Pharmacology 26: 1009–1014 (1977).
Waxman, S. and Herbert, V.: Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow. New England Journal of Medicine 280: 1316 (1969).
Weinstein, G.D.: Commentary: Three decades of folic acid antagonists in dermatology. Archives of Dermatology 119: 525–527 (1983).
Wells, D.G.: Folic acid and neuropathy in epilepsy. Lancet 1: 146 (1968).
Wells, D.G. and Casey, H.J.: Lactobacillus casei CSF folate activity. British Medical Journal 3: 834–836 (1967).
Williams, D.L. and Spray, G.H.: The effect of some anticonvulsant drugs on depletion of folate in rats on a vitamin B12deficient diet. British Journal of Haematology 33: 273–278 (1976).
Wu, A.; Chanarin, I.; Slavin, G. and Levi, A.J.: Folate deficiency in the alcoholic — its relationship to clinical and haematological abnormalities, liver disease and folate stores. British Journal of Haematology 29: 469–478 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lambie, D.G., Johnson, R.H. Drugs and Folate Metabolism. Drugs 30, 145–155 (1985). https://doi.org/10.2165/00003495-198530020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198530020-00003